Skip to main content

Table 1 Risk group classification for localized prostate cancer according to the National Comprehensive Cancer Network guidelines

From: Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience

 

T Stage

PSA (ng/ml)

Gleason score

(Very) low risk

T1–T2a

< 10

2–6

Intermediate risk

T2b-c

10–20

7

(Very) high risk

T3a-b

>20

8–10